HomeTOP STORIESEyePoint outlines top-line Phase III DURAVYU data for wet AMD expected mid-2026... EyePoint outlines top-line Phase III DURAVYU data for wet AMD expected mid-2026 as cash runway extends into Q4 2027 By rogerjudd November 5, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleHorace Mann raises 2025 core EPS guidance to $4.50-$4.70 as all segments exceed targetsNext articleLimbach targets 70%–80% ODR revenue mix and 35%–40% long-term gross margins as integration of Pioneer Power advances latest articles RxSight Non-GAAP EPS of -$0.04 beats by $0.19, revenue of $30.3M beats by $4.67M FICO Non-GAAP EPS of $7.74 beats by $0.38, revenue of $515.7M beats by $1.78M A Strategic Buyer’s Guide to PE Exits Judge Berates Justice Dept. in Its Prosecution of Comey How Trade Tensions Sent Automakers Scrambling for Chips Right-Wing Media Warns of Socialism and Chaos After Mamdani Victory explore more RxSight Non-GAAP EPS of -$0.04 beats by $0.19, revenue of $30.3M beats by $4.67M FICO Non-GAAP EPS of $7.74 beats by $0.38, revenue of $515.7M beats by $1.78M A Strategic Buyer’s Guide to PE Exits Judge Berates Justice Dept. in Its Prosecution of Comey How Trade Tensions Sent Automakers Scrambling for Chips Right-Wing Media Warns of Socialism and Chaos After Mamdani Victory
